ID   Mel ILG
AC   CVCL_B6LC
SY   ILG
DR   cancercelllines; CVCL_B6LC
DR   Wikidata; Q112129275
RX   Patent=RU2395574;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 697D.
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (from parent cell line).
CC   Transfected with: HGNC; 2434; CSF2.
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: Metastatic; Chest, hypodermis; UBERON=UBERON_0001443+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6KD ! Mel Il
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
RX   Patent=RU2395574;
RA   Berezhnoy A.E., Larin S.S., Gnuchev N.V., Georgiev G.P., Zakharova E.S.,
RA   Lukashina M.I., Baryshnikov A.Y., Demidov L.V., Mikhailova I.N.,
RA   Burova O.S., Morozova L.F., Kozlov A.M.;
RT   "Human melanoma cell line ILG which secretes recombinant granulocytic-
RT   macrophage colony-stimulating factor.";
RL   Patent number RU2395574, 27-Jul-2010.
//